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ABSTRACT Cryptococcus neoformans infections are signiﬁcant causes of morbidity
and mortality among AIDS patients and the third most common invasive fungal in-
fection in organ transplant recipients. One of the main interfaces between the fun-
gus and the host is the fungal cell wall. The cryptococcal cell wall is unusual among
human-pathogenic fungi in that the chitin is predominantly deacetylated to chi-
tosan. Chitosan-deﬁcient strains of C. neoformans were found to be avirulent and
rapidly cleared from the murine lung. Moreover, infection with a chitosan-deﬁcient
C. neoformans strain lacking three chitin deacetylases (cda1Δcda2Δcda3Δ) was found
to confer protective immunity to a subsequent challenge with a virulent wild-type
counterpart. In addition to the chitin deacetylases, it was previously shown that chi-
tin synthase 3 (Chs3) is also essential for chitin deacetylase-mediated formation of
chitosan. Mice inoculated with the chs3Δ strain at a dose previously shown to in-
duce protection with the cda1Δcda2Δcda3Δ strain die within 36 h after installation of
the organism. Mortality was not dependent on viable fungi, as mice inoculated with
a heat-killed preparation of the chs3Δ strain died at the same rate as mice inocu-
lated with a live chs3Δ strain, suggesting that the rapid onset of death was host me-
diated, likely caused by an overexuberant immune response. Histology, cytokine pro-
ﬁling, and ﬂow cytometry indicate a massive neutrophil inﬂux in the mice inoculated
with the chs3Δ strain. Mice depleted of neutrophils survived chs3Δ inoculation, indi-
cating that death was neutrophil mediated. Altogether, these studies lead us to con-
clude that Chs3, along with chitosan, plays critical roles in dampening cryptococcus-
induced host inﬂammatory responses.
IMPORTANCE Cryptococcus neoformans is the most common disseminated fungal
pathogen in AIDS patients, resulting in 200,000 deaths each year. There is a press-
ing need for new treatments for this infection, as current antifungal therapy is ham-
pered by toxicity and/or the inability of the host’s immune system to aid in resolu-
tion of the disease. An ideal target for new therapies is the fungal cell wall. The
cryptococcal cell wall is different from the cell walls of many other pathogenic fungi
in that it contains chitosan. Strains that have decreased chitosan are less pathogenic
and strains that are deﬁcient in chitosan are avirulent and can induce protective re-
sponses. In this study, we investigated the host responses to a chs3 strain, a
chitosan-deﬁcient strain, and found that mice inoculated with the chs3 strain all
died within 36 h and that death was associated with an aberrant hyperinﬂammatory
immune response driven by neutrophils, indicating that chitosan is critical in modu-
lating the immune response to Cryptococcus.
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Cryptococcus neoformans is a ubiquitous encapsulated fungal pathogen that causespneumonia and meningitis in immunocompromised individuals. C. neoformans is
the most common disseminated fungal pathogen in AIDS patients, with an estimated
quarter million cases of cryptococcal meningitis each year resulting in200,000 deaths
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(1, 2), and it remains the third most common invasive fungal infection in organ
transplant recipients (3). Current antifungal therapy is often hampered by toxicity
and/or the inability of the host’s immune system to aid in resolution of the disease;
treatment is further limited by drug cost and availability in the resource-limited settings
(4). The acute mortality rate of patients with cryptococcal meningitis is between 10 and
30% in medically advanced countries (5, 6), and even with appropriate therapy, at least
one third of patients with cryptococcal meningitis will undergo mycologic and/or
clinical failure (4). Patients that do recover can be left with profound neurological
sequelae, highlighting the need for more-effective therapies and/or vaccines to combat
cryptococcosis.
One of the main interfaces between the fungus and the host is the fungal cell wall.
Most fungal cell walls contain chitin; however, the cryptococcal cell wall is unusual in
that the chitin is predominantly deacetylated to chitosan. Chitin is a homopolymer of
-1,4-linked N-acetylglucosamine (GlcNAc) and is one of the most abundant polymers
in nature. Immunologically, chitin can induce allergy and strong Th2-type immune
responses (7). Chitin is polymerized from cytoplasmic pools of UDP-GlcNAc by a
multiple transmembrane protein chitin synthase (Chs), and there are eight Chs enzymes
encoded in the C. neoformans genome (8). Chitosan, the deacetylated form of chitin, is
generally less abundant in nature than chitin, but it is found in the cell walls of several
fungal species depending on growth phase (8). Chitosan is not synthesized de novo but
is generated from chitin through enzymatic conversion of GlcNAc to glucosamine
(GlcN) by chitin deacetylases (CDAs), and C. neoformans makes three CDAs (9). Why
Cryptococcus converts chitin to chitosan and what advantages this conversion provides
to the organism are not well understood.
Deletion of a speciﬁc chitin synthase (CHS3) or deletion of all three chitin deacety-
lases causes a signiﬁcant reduction in chitosan in the vegetative cell wall (9). These
chitosan-deﬁcient strains of C. neoformans are avirulent and rapidly cleared from the
murine lung (9). Moreover, infection with a chitosan-deﬁcient C. neoformans strain
lacking three chitin deacetylases, cda1Δcda2Δcda3Δ (called cda1Δ2Δ3Δ throughout this
work ), was found to confer protective immunity to a subsequent challenge with a
virulent wild-type counterpart (10). These ﬁndings suggest that there is an altered host
response to chitosan-deﬁcient strains. Therefore, we wanted to determine the nature of
host immune response to an infection with chitosan deﬁciency caused by the deletion
of the C. neoformans CHS3 gene.
Surprisingly, we observed that all mice inoculated with the chs3Δ strain died within
36 h. Death was not dependent on live organisms or the mouse background. We
hypothesized that the rapid onset of mortality was likely due to an aberrant immune
response. Histology, cytokine proﬁling, and ﬂow cytometry indicate a massive inﬂux of
neutrophils in the mice inoculated with chs3Δ. Mice depleted of neutrophils all survived
inoculation of the chs3Δ strain, indicating that the observed mortality is neutrophil
mediated. Together, these results suggest that chitin synthase 3 (Chs3) is important in
modulating the immune response to Cryptococcus.
RESULTS
Complete deletion and complementation of C. neoformans chitin synthase 3
(Chs3). With better annotation of the cryptococcal genome, we found that our previ-
ously reported chs3Δ strain (8) did not contain a complete deletion of the chs3 gene.
While the protein is not functional, as the catalytic domain was deleted, the original
strain still harbored 689 bp of gene sequence potentially sufﬁcient to encode an
25-kDa protein. As this gene is highly expressed under vegetative growth, the
truncated protein might inﬂuence growth of the mutant strain, its virulence, or the host
immune response to the mutant strain. To eliminate this concern, we generated a
complete deletion of the CHS3 gene, including the 5= untranslated region (UTR) to
delete the promoter as well, in strain KN99 by biolistic transformation. All the isolates
were characterized by diagnostic PCR screening and Southern blot hybridization.
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The original, partial chs3Δ strain exhibited a large number of phenotypes including
changes in morphology with two- to threefold enlarged cells and a budding defect,
temperature sensitivity, leaky melanin, and chitosan deﬁciency, among others (8). Cells
of the new chs3Δ strain with a complete gene deletion exhibited the same morphologic
changes observed in the original strain (Fig. 1A). Additionally, like the original chs3Δ
strain, the new chs3Δ strain is also temperature sensitive (Fig. 1B) and deﬁcient in
chitosan (Fig. 1C). Phenotypically, the new and original chs3Δ strains appear to be very
similar, with the one exception being that the new strain grows faster than the original
strain, perhaps due to the lack of the truncated protein.
Previously we attempted to complement the original chs3Δ strain a multitude of
ways, and all attempts failed, leading us to conclude that the cell wall of the chs3Δ
strain was compromised to a point that the cryptococci could not survive any of the
transformation procedures. (9). With this in mind, we attempted to complement
the new chs3Δ strain using electroporation into the endogenous locus, replacing the
nourseothricin (NAT) resistance marker, and were successful. The complemented strain
(chs3::CHS3) reversed all the observed phenotypes including the changes in morphol-
ogy, temperature sensitivity, and chitosan deﬁciency (Fig. 1A to C). Because the new
chs3 is a complete deletion and we have been able to generate a fully complemented
strain, we focused most of the work described here on the new chs3 strain.
Inoculation with the chs3 strain induces rapid mouse mortality. We have
previously shown that chitosan is essential for growth in the mammalian host. Strains
with three different chitosan deﬁciency genotypes (chs3, csr2, and cda123) all
show rapid pulmonary clearance in a mouse model of cryptococcosis and complete loss
FIG 1 Deletion and complementation of C. neoformans chitin synthase 3 (Chs3). (A) For morphological
analysis, cells were incubated for 2 days in YPD and diluted to an OD650 of 0.2 with PBS. Five microliters
of each cell solution was spotted onto a clean glass slide and photographed at 40. (B) Temperature
sensitivity. Cultures were grown overnight in YPD and then diluted to an OD650 of 1.0. Tenfold serial
dilutions were made in PBS, and 3 l of each diluted sample was plated. The plates were grown for 4 days
at 30°C or 39°C. (C) Quantitative determination of cell wall chitosan by the MBTH assay. Cells were grown
in YPD for 2 days, collected, washed, and used for the assay. Values are the averages  standard
deviations (SD) (error bars) from three biological experiments and are expressed as nanomoles of
glucosamine per milligram (dry weight) of yeast cells. Statistical signiﬁcance is indicated as follows: ***,
P 0.001; NS, not signiﬁcant.
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of virulence (9) when given in an inoculation of 105 CFU. An inoculation of 105 wild-type
(WT) strain KN99 is sufﬁcient to routinely induce disease and cause death at 18 to
20 days postinfection. Mice that received a high inoculation (107 CFU) of the strain
lacking chitin deacetylases, cda123, were also able to clear the infection and were
protected against a subsequent challenge with WT C. neoformans KN99 (10). Notably,
this chitosan-deﬁcient strain is protective even when heat killed (10). Protective immu-
nization is dependent on the inoculum size, as only mice that received 107 CFU of
cda123 were protectively immunized, mice that received a lower inoculation were
not protected (10).
On the basis of these data, we set out to test whether inoculation with other
chitosan-deﬁcient strains would also confer protection. We started this process using
the new chs3 strain, which is chitosan deﬁcient (Fig. 1C). We inoculated C57BL/6 mice
intranasally with 107 CFU of live cda1Δ2Δ3Δ (a concentration that is shown to be
protective for cda123), chs3, chs3::CHS3, or WT C. neoformans KN99 and were
monitored for survival. As expected, mice that received cda1Δ2Δ3Δ all survived the
infection and mice that received the WT KN99 or chs3::CHS3 all died or were eutha-
nized due to morbidity around day 6 (KN99) or day 8 (chs3::CHS3) postinoculation with
this high inoculum (Fig. 2). What was surprising, however, was that the mice inoculated
with chs3 all died within 36 h after instillation of the organism (Fig. 2).
The rapid rate of mortality suggested that death was not due to fungal proliferation
or burden. Furthermore, we previously showed that the original chs3 strain is rapidly
cleared from the host at a lower inoculum (9). On the basis of these ﬁndings, we
examined whether mortality was dependent on viable fungi. We heat killed (HK) WT
KN99, chs3, and chs3::CHS3 strains at 70°C for 15 min. Complete killing was con-
ﬁrmed by plating for CFU. C57BL/6 mice then received an intranasal inoculation with
107 CFU of HK WT KN99, HK chs3Δ, or HK chs3::CHS3 and were monitored for survival.
Mice that received HK WT KN99 or HK chs3::CHS3 all survived the inoculation of
heat-killed cells (Fig. 3A). Conversely, mice that received the HK chs3 strain all died at
the same rate as observed above for mice that received the live chs3 strain (Fig. 2 and
3A), indicating that mortality was not dependent on the viability of the fungi. Support-
ing the conclusion that the observed phenotype was due to loss of Chs3 and not
introduced by a secondary mutation, we also tested the original chs3 strain described
by Baker et al. (11) (see Fig. S1 in the supplemental material) and saw the same rapid
mortality observed in Fig. 3A, indicating that mortality can be attributed to the loss of
Chs3.
Different mouse backgrounds have various susceptibilities to C. neoformans de-
pending on the strain used (11). Due to the strong phenotype observed with chs3 in
the C57BL/6 mice, we wanted to verify that the rapid rate of mortality was not due to
the mouse background. To assess susceptibility in different mouse backgrounds,
FIG 2 Inoculation with the chs3 strain induces rapid mouse mortality. C57BL/6 mice were infected with
107 live CFU of each strain by intranasal inoculation. Survival of the animals was recorded as mortality
of mice for 40 days postinoculation. Mice that lost 20% of the body weight at the time of inoculation or
displayed signs of morbidity were considered ill and sacriﬁced. Data are representative of one experi-
ment with 5 mice for KN99, 5 mice for cda1Δ2Δ3Δ, 10 mice for chs3, and 10 mice for chs3::CHS3.
Virulence was determined using Mantel-Cox curve comparison, with statistical signiﬁcance determined
by the log rank test (***, P 0.001).
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BALB/c or CBA/J mice received an intranasal inoculation with 107 CFU of HK WT KN99,
HK chs3, or HK chs3::CHS3 and were monitored for survival. Regardless of the mouse
background, mice that received HK WT KN99 or HK chs3::CHS3 all survived the
challenge, whereas mice that received HK chs3 all died at the same rate as observed
in the C57BL/6 mice (Fig. 3A to C), indicating that rapid rate of mortality was not a
mouse background phenomenon.
Mortality due to the chs3 strain is dose dependent.We previously reported that
the chs3Δ strain is avirulent and rapidly cleared from the mice (9). Those studies were
performed with a lower inoculum, and in conjunction with our above observations, the
results suggest that chs3Δ-associated mortality may be dose dependent. To test this,
we inoculated C57BL/6 mice with 106, 2.5 106, or 107 CFU HK chs3Δ, and mice were
monitored for survival. The mice that received 107 CFU all died as observed above. In
contrast, mice that received 106 CFU all survived, and although they displayed signs of
morbidity, they recovered. Mice that received 2.5 106 CFU had a 50% mortality rate
where half the animals had succumbed within 24 h postinoculation (Fig. S2). These data
suggest that mortality due to chs3Δ is dose dependent and whatever component(s)
that triggers the overabundant immune response needs to be at a certain concentra-
tion to elicit the response.
A massive inﬂammatory response is triggered by chs3 inoculation. The above
data indicate that mice are not dying due to the fungal burden, as death was not
FIG 3 Mortality is not dependent on the viability of the fungi or mouse background. (A to C) C57BL/6
(A), BALB/c (B), or CBA/J (C) mice were inoculated with 107 heat-killed (HK) CFU of each strain by
intranasal inoculation. Survival of the mice was recorded for 20 days postinoculation. Mice that lost 20%
of the body weight at the time of inoculation or displayed signs of morbidity were considered ill and
sacriﬁced. Data are cumulative data from one experiment with 5 mice for KN99, and two experiments
with 5 mice for chs3 and chs3::CHS3 each for a total of 10 mice. Virulence was determined using
Mantel-Cox curve comparison, with statistical signiﬁcance determined by the log rank test (***,
P 0.001).
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dependent on viable fungi in multiple mouse backgrounds (Fig. 3). These data suggest
that the mortality associated with chs3 may be host mediated (12). To test this,
C57BL/6 mice received an intranasal inoculation with 107 CFU HK WT KN99, HK chs3Δ,
or HK chs3::CHS3, and the lungs were processed for histology. For all immune studies,
we chose to use heat-killed fungi to control for fungal burden as the WT KN99 and
chs3::CHS3 strains would rapidly outgrow the chs3 strain and potentially skew our
results. Lungs were processed at 8 h postinoculation, as we could not keep the mice
inoculated with the chs3 strain (chs3-inoculated mice) alive for the full 24 h. The 8-h
time point was chosen, as this was the time the animal started to show signs of
morbidity. The parafﬁn-embedded lungs were sectioned and processed for hematox-
ylin and eosin (H&E) staining. Histological analysis of the infected lung show little
pathology in the lungs of the mice inoculated with either HK KN99 or HK chs3::CHS3
compared to the strong inﬂammatory response in the lungs of the chs3-inoculated
mice at 8 h (Fig. 4). The lungs from mice inoculated with chs3 exhibit abundant foci
of inﬂammation spread across the whole lung section (Fig. 4C) consisting of a profound
amount of mixed inﬂammatory inﬁltrates with enhanced presence of granulocytes
(Fig. 4D and E). Such severe pneumonia and lung damage could explain the mortality
observed in chs3-inoculated mice and indicate that the immune response in the
lungs, albeit robust, is nonprotective and detrimental.
Mortality due to chs3 is not dependent on the signaling components involv-
ing Card9 or MyD88. Other cryptococcal mutants that have defects in the cell wall, like
rim101, have been found to induce a strong proinﬂammatory response and lead to
granulocyte recruitment (13). In addition, it was found that proinﬂammatory cytokine
FIG 4 A massive inﬂammatory response is triggered by chs3Δ. C57BL/6 mice were inoculated with 107
heat-killed CFU of each strain by intranasal inoculation. At 8 h postinoculation, the lungs were harvested,
embedded, sectioned, and processed for hematoxylin and eosin staining. (A to C) HK KN99-inoculated
mice display a limited inﬂammatory response. (D to F) HK chs3-inoculated mice exhibit abundant foci
of inﬂammation (black arrows) spread across the whole lung section consisting of a profound amount of
mixed inﬂammatory inﬁltrates with enhanced presence of neutrophils (green arrows). (G to I) HK
chs3::CHS3-inoculated mice displayed a similar limited inﬂammatory response observed in the HK
KN99-inoculated mice. Images are representative of two independent experiments using three mice per
group.
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production was dependent on the adapter proteins caspase recruitment domain family
member 9 (Card9) and myeloid differentiation primary response 88 (MyD88) (14, 15).
Because of these data, we next tested whether Card9 or MyD88 was important in the
response to chs3Δ infection. To test this, C57BL/6, Card9/, or MyD88/ mice
received an intranasal inoculation with 107 CFU of HK chs3 and were monitored for
survival. We observed no difference in survival with Card9/ or MyD88/ mice
compared to WT mice infected with chs3 (Fig. S3), indicating that rapid rate of
mortality was not dependent on these two adapter proteins.
chs3 induces a strong proinﬂammatory cytokine response. Because we ob-
served signiﬁcant inﬁltration of immune cells in the lungs of chs3-inoculated mice
(Fig. 4D and E), we next assessed the cytokine/chemokine produced. To do this,
C57BL/6 mice received an intranasal inoculation with 107 CFU HK WT KN99, HK chs3Δ,
or HK chs3::CHS3, and at 8 h postinoculation, homogenates were prepared from the
lungs of each group as well as a phosphate-buffered saline (PBS) control group.
Cytokine/chemokine responses were determined from the lung homogenates using
the Bio-Plex protein array system. We observed an increase in multiple cytokines
(Fig. S4); however, there was a signiﬁcant increase in the chemokines KC (keratinocyte-
derived chemokine) (Fig. 5A) and granulocyte colony-stimulating factor (G-CSF)
(Fig. 5B), as well as extremely high levels of interleukin 6 (IL-6) (Fig. 5C) in chs3-
inoculated mice compared to PBS-, HK WT KN99-, or HK chs3::CHS3-inoculated mice.
This cytokine proﬁle is indicative of a strong neutrophilic response in the lungs, which
correlates with the histology data above, indicating an enhanced presence of granu-
locytes (Fig. 4).
A signiﬁcant increase in neutrophil recruitment in the lungs of chs3-
inoculated mice. Since both the histology and cytokine analysis indicate a strong
inﬂammatory response, we wanted to identify the responding cells. For this, C57BL/6
mice received an intranasal inoculation with 107 CFU of HK WT KN99, HK chs3, or HK
chs3::CHS3, and at 8 h postinoculation, pulmonary leukocytes were isolated from the
lungs of each group of mice by enzymatic digestion and subjected to ﬂow cytometry
analysis for leukocyte identity (Fig. S5). Consistent with the above histology data, there
was a signiﬁcant increase in the total number of immune cells in the lungs of
chs3-inoculated mice (Fig. 6A). In addition, there was a signiﬁcant increase in both the
total number and percentage of neutrophils in the lungs of chs3-inoculated mice
compared to the WT KN99- or HK chs3::CHS3-inoculated mice (Fig. 6B and C). We did
not observe a signiﬁcant change in any of the other cell types assayed (Fig. S6).
Depletion of neutrophils protects chs3-inoculated mice. Due to the signiﬁcant
increase in neutrophil recruitment to the lungs of mice inoculated with the chs3
FIG 5 chs3 induces a strong proinﬂammatory cytokine response. C57BL/6 mice were inoculated with 107 heat-killed CFU of each strain by intranasal
inoculation. At 8 h postinoculation, homogenates were prepared from the lungs of the mice of each group. Cytokine/chemokine responses were determined
from the lung homogenates using the Bio-Plex protein array system. Data are cumulative data for one experiment with 5 mice for PBS and KN99 and for two
experiments with 5 mice for chs3 and chs3::CHS3 each for a total of 10 mouse experiments. Values are means  standard errors of the means (SEM) (error
bars). Each circle represents the value for an individual mouse. Statistical signiﬁcance: ***, P 0.001.
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strain, we sought to determine the role of neutrophils in the rapid mortality observed
in these animals. To test this, C57BL/6 mice were injected with 200 g of anti-Ly6G
(1A8), an antibody that speciﬁcally depletes neutrophils (16, 17), or an isotype antibody
24 h before intranasal inoculation with 107 CFU of HK chs3 and monitored for survival.
Mice were injected with antibody every 24 h for the ﬁrst 5 days postchallenge. After day
5, the mice were injected every 48 h. This antibody is usually injected every 48 h;
however, with the high number of neutrophils recruited (Fig. 6) and the elevated levels
of neutrophil growth factors (Fig. 5), we elected to increase the number of the initial
injections to ensure neutrophil depletion. Mice that were treated with the isotype
antibody all died at the same rate as observed above with HK chs3 (Fig. 3A and 7A),
whereas mice that were treated with anti-Ly6G all survived (Fig. 7A), indicating that
death was neutrophil mediated. To conﬁrm this ﬁnding, we repeated the experiment in
BALB/c and CBA/J mice. Consistent with our ﬁndings for C57BL/6 mice, mice that were
depleted of neutrophils all survived inoculation with HK chs3, whereas mice treated
with the isotype antibody all died regardless of mouse background (Fig. 7B and C).
These data demonstrate that the rapid rate of mortality observed in mice inoculated
with chs3 is neutrophil dependent.
DISCUSSION
We have previously shown that deletion of a speciﬁc chitin synthase (CHS3) or
deletion of all three chitin deacetylases causes a signiﬁcant reduction in chitosan in the
vegetative cell wall (9). These chitosan-deﬁcient strains of C. neoformans were found to
be avirulent and rapidly cleared from the murine lung (9). Moreover, infection with a
chitosan-deﬁcient C. neoformans strain lacking three chitin deacetylases (cda1Δ2Δ3Δ)
was found to confer protective immunity to a subsequent challenge with a virulent
wild-type counterpart (10). These ﬁndings suggest that there is an altered host response
to chitosan-deﬁcient strains. Surprisingly, we observed that mice inoculated with chitosan-
deﬁcient chs3 all died within 36 h (Fig. 2 and 3), and death was associated with an
aberrant hyperinﬂammatory immune response, indicating that chitosan is critical in mod-
ulating the immune response to Cryptococcus.
While the chs3 strain is chitosan deﬁcient like the cda1Δ2Δ3Δ strain, the fact that
the immune responses to the two strains are different is not surprising, as there are
some key differences in the strains. Both strains have a budding defect that we have
associated with the lack of chitosan; however, the lack of chitosan does not explain why
the chs3 cells are so much larger than the cda1Δ2Δ3Δ or WT cells (Fig. 1) (18).
Biochemically, there are signiﬁcant differences in the amount of total chitinous material
FIG 6 A signiﬁcant increase in neutrophil recruitment in chs3-inoculated mice. C57BL/6 mice were inoculated with 107 heat-killed CFU of each strain by
intranasal inoculation. At 8 h postinoculation, pulmonary leukocytes were isolated from the lungs of mice of each group and subjected to ﬂow cytometry
analysis (see Table S2 for antibodies and Fig. S5 for gating strategy). (A) Total number of leukocytes. (B and C) Total number (B) and percentage (C) of neutrophils
(CD11b/CD24/Ly6G/CD45). Data are cumulative of one experiment with 5 mice for KN99 and two experiments with 5 mice for chs3 and chs3::CHS3 each
for a total of 10 mouse experiments. Values are means standard errors of the means (SEM). Each circle represents the value for an individual mouse. Statistical
signiﬁcance: ***, P 0.001.
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(total chitin plus chitosan) in the two strains. The cda1Δ2Δ3Δ strain has all the chitin
synthases intact, including Chs3, and it makes chitin, but it cannot be deacetylated to
chitosan, so it has approximately the same amount of total chitinous material as the
wild type, but it is all chitin, with no chitosan. On the other hand, the chs3 strain has less
total chitinous material than the wild type, but it has slightly increased amounts of chitin
and lacks chitosan (8). CHS3 is a highly expressed chitin synthase and is responsible for the
synthesis of the majority of the chitin that is converted to chitosan (18). The reduced
amount of total chitinous material found in the chs3 strain could explain why it is more
sensitive than the cda1Δ2Δ3Δ strain to some, but not all, of the cell wall stressors like
caffeine, Congo red, and calcoﬂuor white (18). The different amounts of total chitinous
material could also lead to exposure of other cell wall components that are known to be
immunogenic like mannans or glucans. Additionally, the temperature sensitivity observed
in the chs3 strain (Fig. 1) (18) is not found in the cda1Δ2Δ3Δ strain, indicating that the lack
of chitosan is not linked to the ability to grow at high temperatures. With the multiple
defects in the chs3 strain, the hyperinﬂammatory immune response induced by chs3
could be due to other factors in addition to the chitosan deﬁciency.
The immune response to Cryptococcus, as well as the magnitude of the response,
can play a protective or detrimental role. Our data ﬁt well within the damage-response
FIG 7 Depletion of neutrophils protects chs3-inoculated mice. (A to C) C57BL/6 (A), BALB/c (B), or CBA/J
(C) mice were inoculated with 107 heat-killed CFU of each strain by intranasal inoculation. Prior to
inoculation and throughout the experiment, mice were treated with isotype antibody or anti-Ly6G
antibody (Ly6G). Survival of the mice was recorded for 20 days postinoculation. Mice that lost 20% of
the body weight at the time of inoculation or displayed signs of morbidity were considered ill and
sacriﬁced. Data are cumulative for two independent experiments with 5 mice for chs3 and chs3::CHS3
each for a total of 10 mice. Virulence was determined using Mantel-Cox curve comparison with statistical
signiﬁcance determined by the log rank test (***, P 0.001).
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framework proposed by Casadevall and Pirofski (12) where host damage or beneﬁt is
dependent on the host response. This is represented as a parabolic curve, where too
little of a response to a microorganism can lead to damage caused by the microor-
ganism and too strong of a host response can lead to damage caused by the host
response. This framework is observed in cryptococcus-infected AIDS patients. Too little of
a response can lead to patient death due to the fungus, whereas a hyperactive response
can lead to death caused by immunopathology. AIDS patients treated with antiretroviral
therapy often develop cryptococcal immune reconstitution inﬂammatory syndrome (IRIS),
which is an exaggerated and frequently deadly inﬂammatory reaction that complicates
recovery from immunodeﬁciency (19). Cryptococcal IRIS emphasizes the potential role of
the host immune system in mediating host damage and disease symptoms.
There is reason to study mutants that induce an aberrant hyperinﬂammatory
immune response, as similar responses like increased cytokine levels and strong
neutrophil responses have been observed with fungal IRIS (19–22). Cryptococcal IRIS
develops in 8 to 49% of patients with known cryptococcal disease before antiretroviral
therapy (23). Neutropenia from chemotherapy or stem cell transplant is a risk factor for
invasive aspergillosis (IPA). However, fast recovery of neutrophils in patients with IPA
has been associated with the induction of IRIS in about one quarter of these patients
(21, 22). The pathogenesis of IRIS is poorly understood, and prediction of IRIS is not
currently possible. Innate immune cells, such as monocytes and neutrophils, are of
increasing interest in IRIS pathophysiology, since granuloma appears to be frequently
found in IRIS lesions (19). Additionally, at the time of IRIS onset, multiple proinﬂam-
matory cytokine are detected, including IL-6 (20). Further study of the chs3 immune
response could advance our understanding of host immune mechanisms involved in an
inappropriately strong immune response to Cryptococcus, like those seen in immune
reconstitution inﬂammatory syndrome. These studies have the potential to advance our
understanding of a signiﬁcant problem in the management of cryptococcal patients.
Other cryptococcal mutants that have defects in the cell wall, like rim101 and
mar1, have been found to induce a strong proinﬂammatory response and lead to
neutrophil recruitment (13–15) but not to the order of magnitude observed with chs3.
Neutrophils have a complicated role in the cryptococcal immune response. While
neutrophils can kill C. neoformans, the fungus can modulate the neutrophil response.
Cryptococcal capsular and cell wall components can inhibit neutrophil migration (24,
25) and the production of neutrophil extracellular traps (26). In the brain, neutrophils
have been shown to be important in clearance of the fungus from the microvasculature
(27, 28). Neutrophil depletion in a protective immunization model did not affect
pulmonary fungal burden, indicating that neutrophils are not required for clearance
(16) or for the secondary response (17). These data further support the observation by
Mednick et al. that neutropenic mice given a pulmonary C. neoformans infection
survived signiﬁcantly longer than control mice that had an intact neutrophil compart-
ment (29), therefore indicating that neutrophils are not necessary for protective responses
against cryptococcal infection. We observed a signiﬁcant increase in neutrophil recruitment
to the lungs of mice inoculated with the chs3 strain (Fig. 6B and C). Mice inoculated with
HK chs3 and depleted of neutrophils all survived, whereas the isotype-treated mice all
died (Fig. 7), indicating a detrimental role for neutrophils. Further supporting a harmful role
for neutrophils, mice with genetically induced neutrophilia appear to have increased
susceptibility to cryptococcal disease (30). More work is needed to elucidate our under-
standing the cryptococcus-neutrophil interactions.
We have shown that chs3 induces massive production of IL-6, KC, and G-CSF as
well as a strong neutrophilic response. However, the source of these cytokines, as well
as their role in the pathology, of chs3 is not known. It is likely that the cytokines are
produced by the lung epithelium and/or resident immune cells, since the response is
so fast, but other immune cells, such as the recruited neutrophils, could play a role. We
plan to assay this by utilizing knockout and depletion strategies. Additionally, as
mortality due to chs3 is dose dependent and associated with a highly inﬂamed lung,
we hypothesize that there are cellular components from chs3 that elicit the rapid
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onset of death. We plan to test this by fractionating WT, chs3Δ, and chs3::CHS3
cryptococcal cells to identify the immune activating components.
In summary, we have shown that inoculation with either live or dead cells from the
chs3Δ strain leads to death of the mice within 36 h. The rapid onset of death is likely
due to an aberrant hyperinﬂammatory immune response, as mortality was not depen-
dent on viable fungi. Histology, cytokine proﬁling, and ﬂow cytometry indicate a
massive inﬂux of neutrophils in the mice inoculated with chs3Δ. Depletion studies show
a damaging role for neutrophils in the response to chs3Δ. Altogether, chitosan may play
a major role in the immune response to C. neoformans. In addition, the response to
chitosan-deﬁcient C. neoformans seems to depend on the type of genes deleted, as not
all chitosan-deﬁcient strains induce the same immune response.
MATERIALS AND METHODS
Fungal strains and media. C. neoformans strain KN99 was used as the wild-type strain and as
progenitor of mutant strains. Strains were grown in YPD broth (1% yeast extract, 2% Bacto peptone, and
2% dextrose) or on YPD solid medium containing 2% Bacto agar. Selective YPD medium was supple-
mented with 100 g/ml nourseothricin (NAT) (Werner BioAgents, Germany).
Strain construction. Gene-speciﬁc deletion construct of the chitin synthase 3 gene (CNAG_05581)
was generated using overlap PCR gene technology described previously (31, 32) and included the
nourseothricin resistance cassette. The primers used to disrupt the genes are shown in Table S1 in the
supplemental material. The Chs3 deletion cassette contained the nourseothricin resistance cassette,
resulting in a 1,539-bp replacement of the genomic sequence between the regions of primers 3-Chs3 and
6-Chs3 shown in uppercase in Table S1. The construct was introduced into the KN99 strain using
biolistic techniques (33). To generate a CHS3 complemented strain, we replaced the NAT resistance
cassette in the chs3 deletion strain with the native CHS3 gene sequence by electroporation (34) and
screened for NAT sensitivity.
Morphological analysis. Cells were incubated for 2 days in YPD medium at 30°C with shaking and
diluted to an optical density at 650 nm (OD650) of 0.2 with phosphate-buffered saline (PBS). Five
microliters of each cell solution was spotted onto a clean glass slide and photographed using an
Olympus BX61 microscope.
Evaluation of temperature sensitivity. Wild-type, chs3 deletion, and chs3::CHS3 complemented
strains were grown in liquid YPD for 2 days at 30°C with shaking. Cells were diluted to an OD650 of 1.0,
and 10-fold serial dilutions were made. Five microliters of each dilution were spotted onto YPD plates,
and the plates were incubated for 2 or 3 days at 30°C and 39°C and photographed.
Cellular chitosan measurement. As previously described, MBTH (3-methyl-2-benzothiazolinone
hydrazone)-based chemical method was used to determine the chitin and chitosan content (35). In brief,
cells were grown in liquid YPD for 2 days at 30°C with shaking collected by centrifugation. Cell pellets
were washed two times with PBS (pH 7.4) and lyophilized. The dried samples were resuspended in water
ﬁrst before adding KOH to a ﬁnal concentration of 6% KOH (wt/vol). The alkali-suspended material was
incubated at 80°C for 30 min with vortexing periodically to eliminate nonspeciﬁc MBTH reactive mole-
cules from the cells. Alkali-treated material was then washed several times with PBS (pH 7.4) to make sure
that the pH of the cell suspension was brought back to neutral pH. Finally, the cell material was
resuspended in PBS (pH 7.4) to a concentration of 10 mg/ml in PBS (by dry weight), and 0.1 ml of each
sample was used in the MBTH assay (36).
Mice. BALB/c (catalog no. 000651), CBA/J (catalog no. 000656), C57BL/6 (catalog no. 000664),
Card9/ (catalog no. 028652), and MyD88/ (catalog no. 009088) mice were obtained from Jackson
Laboratory (Bar Harbor, ME). BALB/c and C57BL/6 mice obtained from Jackson Laboratory are also known
as BALB/cJ and C57BL/6 mice, respectively. All mice were 6 to 8 weeks old at the time of inoculation. All
animal protocols were reviewed and approved by the Animal Studies Committee of the Washington
University School of Medicine and conducted according to National Institutes of Health guidelines for
housing and care of laboratory animals.
Pulmonary inoculations. Strains were grown at 30°C and 300 rpm for 48 h in 50ml YPD. The cells were
centrifuged, washed in endotoxin-free 1 PBS, and counted with a hemocytometer. For studies utilizing
heat-killed organisms, after being diluted to the desired cell number in PBS, the inoculum was heated at 70°C
for 15 min. Complete killing was assayed by plating for CFU. Mice were anesthetized with an intraperitoneal
injection (200l) of ketamine (8mg/ml)-dexmedetomidine (0.05mg/ml) mixture and then given an intranasal
inoculation with 1 107 CFU of live or heat-killed organism in 50l of sterile PBS. Anesthesia was reversed
by an intraperitoneal injection of (200 l) of antipamezole (0.25mg/ml). The mice were fed ad libitum and
monitored daily for symptoms. For survival studies, mice were sacriﬁced when body weight fell below 80%
of weight at the time of inoculation. For cytokine analysis, ﬂow cytometry studies, and histology, mice were
euthanized 8 h postinoculation by CO2 inhalation, and the lungs were harvested.
Histology. Mice were sacriﬁced according to approved protocols and perfused intracardially with
sterile PBS, and the lungs were inﬂated with 10% formalin. Lung tissue was then ﬁxed for 48 h in 10%
formalin and submitted to HistoWiz Inc. (Brooklyn, NY) for histology using standard operating procedures
and fully automated workﬂow. Samples were processed, embedded in parafﬁn, cut into 4-m sections,
and stained using hematoxylin and eosin (H&E). After staining, sections were dehydrated and ﬁlm
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coverslipped using a TissueTek-Prisma and Coverslipper (Sakura USA, Torrance, CA). Whole-slide scan-
ning (40) was performed on an Aperio AT2 instrument (Leica Biosystems, Wetzlar, Germany).
Cytokine analysis. Cytokine levels in lung tissues were analyzed using the Bio-Plex protein array
system (Bio-Rad Laboratories, Hercules, CA). Brieﬂy, lung tissue was excised and homogenized in 2 ml of
ice-cold PBS containing 1 Pierce protease inhibitor cocktail (Thermo Fisher Scientiﬁc, Rockford, IL). After
homogenization of the lung tissue, Triton X-100 was added to a ﬁnal concentration of 0.05%, and the
samples were clariﬁed by centrifugation. Supernatant fractions from the pulmonary homogenates were
then assayed using the Bio-Plex Pro Mouse Cytokine 23-Plex (Bio-Rad Laboratories) for the presence of
interleukin 1 (IL-1), IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-17A,
granulocyte colony-stimulating factor (G-CSF), granulocyte monocyte colony-stimulating factor (GM-
CSF), gamma interferon (IFN-), chemokine (C-X-C motif) ligand 1 (CXCL1)/keratinocyte-derived chemo-
kine (KC), chemokine (C-C motif) ligand 2 (CCL2)/monocyte chemotactic protein 1 (MCP-1), CCL3/
macrophage inﬂammatory protein 1 (MIP-1), CCL4/MIP-1, CCL5/regulated upon activation, normal T
cell expressed and secreted (RANTES), and tumor necrosis factor alpha (TNF-).
Flow cytometry. Cell populations in the lungs were identiﬁed by ﬂow cytometry. Brieﬂy, lungs from
individual mice were enzymatically digested at 37°C for 30 min in digestion buffer (RPMI 1640 containing
1 mg/ml of collagenase type IV). The digested tissues were then successively passed through sterile 70-
and 40-m-pore nylon strainers (BD Biosciences, San Jose, CA). Erythrocytes in the strained suspension
were lysed by incubation in NH4Cl buffer (0.859% NH4Cl, 0.1% KHCO3, 0.0372% Na2EDTA [pH 7.4];
Sigma-Aldrich) for 3 min on ice, followed by the addition of a twofold excess of PBS. The leukocytes were
then collected by centrifugation, resuspended in sterile PBS, and stained using the LIVE/DEAD Fixable
Blue Dead Cell Stain kit (1:1,000; Invitrogen, Carlsbad, CA) for 30 min at 4°C in the dark. Following
incubation, samples were washed and resuspended in ﬂuorescence-activated cell sorting (FACS) buffer
(PBS, 0.1% bovine serum albumin [BSA], 0.02% NaN3, 2 mM EDTA) and incubated with CD16/CD32 (Fc
Block; BD Biosciences, San Jose, CA) for 5 min. For ﬂow cytometry, 1 106 cells were incubated for 30 min
at 4° C in the dark with optimal concentrations of ﬂuorochrome-conjugated antibodies (see Table S2 for
a list of the antibodies, antigens, clones, and sources) diluted in brilliant stain buffer (BD Biosciences).
After three washes with FACS buffer, the cells were ﬁxed in 2% ultrapure paraformaldehyde. For data
acquisition, 	200,000 events were collected on a BD LSRFortessa X-20 ﬂow cytometer (BD Biosciences,
San Jose, CA), and the data were analyzed with FlowJo V10 (TreeStar, Ashland, OR). The absolute number
of cells in each leukocyte subset was determined by multiplying the absolute number of CD45 cells by
the percentage of cells stained by ﬂuorochrome-labeled antibodies for each cell population analyzed.
Neutrophil depletion. Mice were depleted of neutrophils via intraperitoneal (i.p.) administration of
200 g anti-Ly6G (clone 1A8; BioXcell) in 100 l. Control mice received 200 g IgG2a isotype control
antibody (clone 2A3; BioXcell) in 100 l. Depletions were started 24 h prior to challenge, and the mice
were injected every 24 h for the ﬁrst 5 days postchallenge. After day 5, the mice were injected every 48 h.
Statistics. Data were analyzed using GraphPad Prism, version 8.0 (GraphPad Software, Inc., La Jolla,
CA). The one-way analysis of variance (ANOVA) with the Tukey’s multiple-correction test was used to
compare more than two groups. Kaplan-Meier survival curves were compared using the Mantel-Cox log
rank test. P values of 0.05 were considered signiﬁcant.
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